Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Current BUY to SELL ratio is 4.5M vs 2.9M
Great way to start the day.
Be well and prosper...
Great discernment! I concur!
Your estimate sounds very reasonable.
The model I use for estimating ENZC's 12 Month PPS moving forward is CytoDyn who has developed the Monoclonal Ab "Leronlim" which is a humanized IgG4 mAb that blocks CCR5, a cellular receptor important in HIV infection.
Although it has shown to be effective in various clinical trials in some patients, it is NOT curative, NOT Monotherapy, AND it has a far inferior capacity to treat HIV AND it also requires dual administration 3X/week of Standard of Care (HAART) Drug Therapy that carries multiple potential side effects including organ damage.
Importantly, it has NOT been shown to be effective in multiple HIV sub-types, nor prevent viral escape, and at best in general, it helps lower viral load to a moderate degree, but NOT in all patients.
MY POINT?? Cytodyn's 52 week trading history shows it went from $0.26 cents to $10, but yet it's not even in the same league as Enzc-BioClonetics Clone-3 Ab, NOT even close!
Therefore IMO, I envision Enzc-Bioclonetics to easily climb into the $5-$10 PPS trading range well within the next 12 months from now if not HIGHER, especially with things moving forward like they are, i.e. Merger finalized any day, SEC filings coming current, getting things underway at Texas A&M-Warp Speed Fast Tack initiative, Dr. Moss on board, funding applications with NIH/NSF, forthcoming Primate Studies at U.C. Davis, and likely the soon appearance of a BigPharma partner being named for formal patient trials, and planning for production and global commercialization of their Monotherapy HIV Vaccine that might include Covid-19 when it's all said and done.
All I'm saying is A LOT can happen within the next 12 months based on what we now know, that could easily cause the company's stock to soar, notwithstanding the potential of a Big Pharma BUY OUT!...a very likely possibility!!!
The fundamental reason why??? Disruption Biotechnology!
Please keep in mind that ALL the above is ONLY AN OPINION...NOTHING ELSE, although I believe it is a reasonable "comparative" analogy estimate!
Be well and prosper...
BIG SELL OFF LAST HOUR OF TRADING, i.e. 71.6M SELL VS 63.0M BUY
It should be the exact opposite..
SELLERS/FLIPPERS ARE GOING TO BE SORRY NOT LONG FROM NOW!
But hey, their major loss is going to be all Buy/Holders GAIN!
Very glad to SNAP UP thousands of shares at this level that I consider a GIFT!! It's almost like FREE SHARES! LOL!
Just added another 50,000 at the current absurd & ridiculous low PPS! Now well in the Multi-Million Share Level range and plan to increase my position WAY beyond what it already is!
Be well and prosper..
THIS IS BEING OVER-SOLD!!!
The SELL Volume has risen further and is NOW 7M HIGHER than the BUY Volume.
The people selling this stock at these levels are going to regret it when they see the PPS sail past $1, then shoot up to $5 in the near future, OR get BOUT OUT FIRST!!!
Be well and prosper...
SELL VOLUME JUST WENT UP TO 58M i.e. 2M HIGHER than Buy Vol which is the reason for the gradually falling PPS. But hey, it's all GOOD!
Just SNAPPED UP several thousand more SHARES!
ADDING ON ANY AND ALL DIPS!!!
Are you North of 5 Million Shares? I'm aware of some people here that are holding 10M+ Shares that got in at the .0000 and .000 range. I made it in at close to the .000 range.
Actually it's the Float not the O/S that matters because it's the Float that's being traded. The more the Float is bought up the less shares available therefore the PPS rises. It's directly related to supply vs demand and in addition to any fundamentals in play, positive news, mergers, etc.
If more of the O/S is added to the Float that's what dilution is about which would likely push the PPS down.
I could be wrong but I don't think so.
It's VERY CLEAR to me there's a Coordinated Pump & Dump scheme going on for some time now. Today was the first it became resounding clear to me!
But hey, that's ok for now for reason it allows investors to SNAP UP Shares at these prices which is exactly what I've been doing and will continue to do as long as this matter persists.
They will all get BLOWN AWAY when the PPS can no longer be held down in the penny-sub penny range.
What I discern are dozens of these Pump & Dump Gang participants working together in a coordinated effort who bought up Mega-Millions of Shares when ENZC was trading in the 0.0001 to 0.0009 range, and they come out in force as the PPS is moving up, drop (SELL) millions of shares in a coordinated effort at Market Open in a systematic manner, then re-purchase at the bottom of the day, then repeat their little wash & rinse cycle daily!
It's very obvious what we're seeing here.
Does anyone have a point of view on this, i.e. do you think this will continue when the PPS rises sharply?
Be well and prosper...
Many great points! Thanks
The valuation you assigned of at least $100/Share sounds very reasonable Post-Merger but the question is when?
I don't anticipate this stock to immediately jump to that level although it would be wonderful. I do believe however that at some point in the near future the PPS will be a lot higher,IMO North of $250, but it will likely be bought out before then and continue to move UP!
My post was intended only as an interesting comparison to Cytodyn that shot UP from $0.26 to $10 within the past 52 weeks.
So the way I see it, ENZC will do A LOT better in our share price movement upward due to our superior Clone-3 Ab that clearly represents Disruption Biotechnology relative to HIV treatment and a host of other infectious disease viruses.
What we do know for certain is post Merger sky's the limit for the PPS with ENZC on track to out perform any comparative Biotech on the Stock Exchange!
Be well and prosper...
Be well and prosper....
ENZC ON THE RISE!!!
A GIANT IS AWAKENING!!!
A GENUINE GLOBAL POWER PLAYER...
RIGHT TIMING...
RIGHT PLAYERS...
MASSIVE SUPPORT...
DISRUPTIVE BIOTECHNOLOGY...
HUNDREDS OF MILLIONS OF HUMAN LIVES SAVED...
NEAR ERADICATION OF HIV-AIDS...AND POSSIBLY COVID-19
ENZC...THE MILLIONAIRE MAKER...
SHOT CALLER SAYS $5-10 WITHIN 1-YEAR!!!
Don't believe it's possible??...take a close look at Cytodyn's (CYDY) 52-Week Trading History ($0.26 to $10) that has a FAR INFERIOR Monoclonal Ab compared to ENZC's Clone-3.
https://finance.yahoo.com/quote/CYDY?p=CYDY&.tsrc=fin-srch
Clone-3 runs circles around CytoDyn's mAb hands down!
WHY?? Clone-3 is single does Monotherapy w/o side effects and is curative in 95% of all known HIV strains; whereas CYDY requires tandem administration with Standard HIV Drug Regimens that have all kinds of terrible side effects AND their AB does NOT have viral escape capacity therefor it is NOT curative, but only "lowers" HIV blood titers by up to 50-60% in some patients.
The Clone-3 Patent alone all by itself is worth $$Billions$$ of Dollars that any MAJOR BIOTECH player would be more than willing to straight up BUY ALL CASH instantly given the opportunity!
Some of you will be Millionaires at 0.05,0.10,0.20..etc...others at 0.50-$1+
ENZC-BIOCLONETICS HOLDS THE GOLD...NO COMPARISON TO ANY BIOTECH IN EXISTENCE!
GREAT POINT!
Here's great information of this subject on the links below:
https://www.forbes.com/advisor/investing/capital-gains-tax/
https://www.investopedia.com/articles/personal-finance/101515/comparing-longterm-vs-shortterm-capital-gain-tax-rates.asp
Be well and prosper ...
EXCELLENT POST!!!
...and just think,based on those brothers hard work, for which they should be acknowledged and rewarded as they have, but nevertheless Pfizer bringing their science to commercialization is NOT curative!
It is however a MAJOR contribution to clinical medicine in treating Covid-19 but it doesn't necessarily have the ability to treat evolving mutations of this virus.
This is not intended to down play what they accomplished, but the reality is, VIRUSES MUTATE given enough time which is WHY the science behind ENZC is FAR SUPERIOR to anything in existence due to the Clone -3 Antibody's capacity to prevent "viral escape".
It is my discernment that since Covid-19 & HIV Viruses have similar structural elements and the Clone-3 Antibody has the capacity to prevent Viral Escape on MOST HIV strains neutralizing up to 95% of them, that this might also apply to Covid-19 which is included in ENZC's scientific discovery process.
Either way, ENZC-BioClonetics is unequivocally ON TRACK to soon become the largest Market Cap Biotech traded on the Stock Exchange just based on their "disruptive science technology" relative to HIV treatment as a stand alone curative Monotherapy. If however they succeed in the same manner with a highly effective Covid-19 vaccine like they have with HIV where it prevents viral escape in the current strain as well as evolving strains, then they will OWN THE PHARMACEUTICAL MARKET on treatment for BOTH HIV & Covid-19!
We already know they're on track to own HIV treatment in the pharmaceutical industry, hands down!
There really isn't any other way of looking at this, but congratulations to Andreas & Thomas Struengmann for their incredible contribution to Medical Science and also Pfizer's role in bringing their Covid-19 vaccine to market at a time when it is desperately needed!
ENZC-BioClonetics....a rising GIANT is in our midst!!!
All you need is for ENZC to hit $1.57 with your 638,000 Shares and you'll have your Million Dollar Pay Day!
You would easily be able to buy a nice house and pay all cash for it depending on where it's located and it's sq/ft range.
May I recommend Las Vegas, Nevada! You'll get more bang for you buck and you'll find amazing new homes throughout Henderson Clark County.
$300,000 range, no problem whatsoever!
On the following link you will find MANY amazing homes for sale in that price range that you will not likely find anywhere else, as these are mostly all custom homes, that anywhere else in the U.S. would be double or triple this price range....enjoy!
RIGHT!!! Based on my experience, that's ALWAYS the way it is!
What I have noticed fairly regularly is the PPS tends to trend UP in the first 30 mins or hour in the trading session, THEN it tends to drift DOWN afterwards and often times reaching its lowest PPS within the last hour of trading.
In general, it trends UP early in trading AT OPEN of market, which I now view as a SUCKER PUNCH, and it may stay up for an hour or more like today, but then toward the late middle to end of the trading session the PPS gradually falls.
My recommendation to you is to NEVER BUY at Market OPEN, and NEVER chase the PPS as it's rising. I would say this is a safe bet at lest 50-60% of the time, again in my personal experience.
Hope this helps!
Be well and prosper...
I could get with that for sure!!!
My take is ENZC trading in the $$ range in 2021!
It's GOOD to see ALL the pieces coming into place!!
Lot's of GREAT NEWS back-to-back, filings current, DR. Moss on board, superior Clone3 Ab for BOTH HIV & Covid-19 that unequivocally represents "disruption technology", funding coming into place, Merger about to finalized, further studies set to move forward (Texas A&M, U.C. David) etc., etc......did I miss anything???
Now does everyone see what can happen IF you'r patient???
If you're invested in this Company, you just so happen to be in the right place at the right time at an extraordinary low pps entry point in what could possibly become the largest Market Cap BioTech "Buy Out" candidate to trade on the Stock Exchange! It's really like THAT!!!
I fully expect ENZC to be trading in the $$ range in 2021, transition to NASDAQ, and/or possibly a Big Pharma Buy Out.
AGAIN....THIS IS ONLY AN OPINION NOTHING ELSE!
Be well and prosper...
Well said!
This stock should ALREADY be trading in the $$ range, not less than $2.
I believe that within a YEAR it will be trading $5-$10, EASILY!!
Like you said there are OTC stocks out there that have absolutely nothing solid going on in their progress, AND, related to things that are not life changing, so YES...you are absolutely correct!
Be well and prosper....
Sounds reasonable! BUT, if not E. Lilly then another Big Pharma, but Lilly is the most likely partner! IMO
Be well and prosper...
That's a good question, but nevertheless I posted what I saw on my Live Trade Account screen AFTER HOURS, just like I said.
This MIGHT of been delayed last minute trade levels within seconds of market close??? Only speculation.
To me, it makes absolutely NO DIFFERENCE whatsoever.
I'll tell you what DOES make a difference to me is to accumulate > 10 Million Shares of this Company's Stock before it takes off which is well in progress!
I posted what I saw after hours today for the reason it seemed interesting, and my thought was may be someone here may have seen the same thing, and guess what, this is NOT the first time it has happen.
At least One person on this Board some weeks ago concurred they saw a similar thing on their eTrade Account after hours.
May be you can call eTrade and ask them.
F.Y.I. Just took a look at my Trade Account and it showed ENZC closed UP 0.0020 + 25.00% to $0.01 after hours!
The following is a cut & past from my Live Trade Account Screen:
ENZC ENZOLYTICS INC
Symbol
ENZC
Last Price/Size
0.01
+0.0020 (+25.00%)
Volume
44.00M
It appears ENZC may make a run to new levels tomorrow 11-13-20
But it's anyone's guess?
Adding/Holding Long AND Strong!
Be well and prosper...
Thank you for the great details!
Apparently I misinterpreted something I quickly glanced at regarding the "750M shares" and recognize I misread in between working, i.e. "lost in translation."
I'm better with clinical facts anyway based on my professional background, than with the language of the stock market, i.e. share structures, restricted, unrestricted, diluted shares, converted, unconverted, etc! All that is Greek to me. You however provided great clarity via your high degree of DD combined with your comprehension of subject matter related to stock market language, which I very much appreciate.
If you can provide your insight as to what you perceive the reason was the PPS dropped like it did today it would be appreciated since this matter has caused much concern to share holders here that are Long like myself, you, and many others who are committed to this Company and have take large positions.
Personally, I'm not worry at all about what the PPS trading range is from day to day just based on my comprehension of what this company is sitting on and who the scientific-medical professionals are behind the scene, especially with the addition of Dr. Moss to the Board.
I will continue to average down on any and all drops and also average up, either way, as I'm in it for the long haul!
Thank you
Be well and prosper...
Thank you for your opinion, everyone is entitle to one.
You know very well I have NOT bashed this stock a single time!
I am LONG NOT a flipper, AND I'm holding several Million Shares and intend to keep adding several million more shares progressively for some time, but for NOW, I'm in a holding pattern.
Opinions are just that, opinions and like anyone else, my opinion is based on my perspective and thought processes.
Be well and prosper...
EXACTLY! Well said! I concur 100% AND I'm holding Multi-Millions of Shares, so my MONEY is definitely where my mouth is!!!
Yes thank you for that! I get your point!
My take today was in the face of learning about the new dilution of 0.75 Billion Shares which I didn't know until today!
So based on this, the PPS will logically trend downward until all the profit taking is over from the dilution combined with impatient holders selling off.
I commented on what I will be doing given this new development which is to wait until all the selling off from Dilution is over, then BUY strongly averaging down into the 0.004 to 0.005 range, OR anything below 0.008.
This is what my personal strategy is, to load up on extremely cheap shares given the incredible opportunity that will soon be a memory.
I'm not going anywhere....remaining in this for the long haul BIG TIME but LOADING UP in the mean time AT THE RIGHT TIME which IMO is South of 0.008.
I believe the current sell off cycle will take at least 3 weeks going into mid December.
Only My Opinion, I could be wrong, but I believe it's an educated one.
See my post within the past 5 mins! That will cheer you up!
Multi-Million Share SELL-OFF TODAY on the ASK and it's only the beginning.
No big deal, but you have to have Faith to see it for what it is!
I perceive this obvious drop in PPS is due to dilution to the O/S of at least 0.75 Billion shares or more which is pushing the PPS DOWN due to that combined to profit taking right off the top!
Don't let this discourage you, hold on to your shares, keep the faith, it's only temporary!
My strategy to counter that is buy huge blocks of shares below 0.008, likely in the 0.004-to-0.005 range which I strongly perceive where this is going, returning to former trading levels within the past 6 months. What an amazing opportunity if that happens!
I'm definitely HOLDING from here onward!
It will eventually TURN UPWARD SKYROCKETING in due time and IMO this is an amazing opportunity to load up on shares!
What goes DOWN must come UP, in this instance in a spectacular manner!!!
Keep the faith and prosper....
Minimum North of $100
Thank you so VERY MUCH for your DD. I took out a recent position in this company after doing my own DD and see it being a definite home run hit! BUT, like many here I started having concerns about this company following through with what they are saying. Delays do occur with these matters and now with your DD, I feel assured they're making natural progress which indeed takes time knowing full well that delay can and do happen. No big deal IMO.
I'm in this company long term. Have never been a flipper.
I also believe they have "disruptive technology" they're bringing to Market, and it's just a matter of time that they achieve their target goals in a step-wise manner.
Thanks again.
Be well and prosper...
Well said EXCELLENT POINTS! I concur 100%!!!
Thanks!
Be well and prosper...
That's EXACTLY CORRECT!!!
Cytodyn doesn't come anywhere close to BioClonetics-ENZC.
The ONLY reason that penny stock company went from the penny range to $10 within 52 weeks on the OTC, is due mainly to them having a Big Pharma partner. That's the fundamental reason why. It has to be because they're still in the midst of clinical trials and have brought NOTHING to market, but yet, not long ago they were trading at $10 PPS. Now they're trading in the $2 range and nothing has really changed for them.
Yes, they're making progress BUT what they have is FAR less of an application for treating HIV than our company. If fact, there's no comparison!
They still have not overcome "HIV viral escape" with their Monoclone Ab, and it still requires the 3X per week dual application with HIV Standard of Care Antiretroviral Therapy (ART) medications that comes with substantial morbidity, side effects, and clinical complications.
Then to boot, their Monoclone Ab has NOT been shown to be effective on most HIV strains.
BioClonetics-ENZC holds the GOLD for not only HIV treatment but its near total eradication of it altogether in up to 95% of all HIV strains with a stand alone Monotherapy that has no side effects! Nothing out there can touch this, NOTHING!.
I say these things with the conviction of me being a clinical trials research physician with NIH scientific background who has been involved in dozens of Big Pharma patient trials.
Now that we are nearing the official Merger with BioClonetics AND we have Dr. Moss on board, these two key developments puts us on an all new level, and IMO Dr. Moss will prove to be the catalyst that fast tracks this company to Warp Speed federal classification of getting our products to market, not only for HIV treatment, but also Covid-19, and a host of other viral infectious diseases.
Now if everyone can just be patient, you're going to be rewarded in the near future when all the pieces fully come into place which is definitely in progress in a major way!!!
I perceive that within a year from now, this company will be trading in the $5-$7 range, and when a Big Pharma partner has been identified and is on board post success with the Primate Studies at U.C. Davis, from that position onward I see this company trading in the $10+ range if not much higher, then shortly after transitioning to NASDAQ with major institutional buying of shares, BUT it's going to take PATIENCE!!! After that, Sky's the Limit maybe even +$300 with or without buy out!
My personal position in all of this is ADD and HOLD in that order, and not to become worried if the PPS drops or trades sideways. I could care less for reason it's simply more opportunity to snap up shares at a ridiculously low PPS. At the current trading range of this company, my target goal ownership is 20M to 50M shares! I'm already well on the way to achieving that!
DON'T WORRY....BE HAPPY!!!
Well said! The Biotech Cytodyn (CYDY) is one of them! Take a look at their 52-Week PPS History, i.e. $0.26 to $10 with ZERO product on the market, ZERO earnings, and still in the clinical trials phase!
But what they do have is a BigPharma partner for conducting Clinical Trials and taking their product to commercialization for their Clone Antibody Leronlimab (PRO 140 ) for treatment of HIV, which doesn't even come close to comparing to BioClonetics Clone 3 Ab.
Also Cytodyn's treatment application is NOT monotherapy like Clone 3, but instead it REQUIRES dual administration with the weekly Standard of Care regime (HAART), which can be up to 3X per week or more and it's associated with major side effects and prolonged co-morbidity and development of serious secondary clinical conditions that can be life threatening.
Their Ab has no reported side effects, BUT the HAART HIV standard of care tandem administration does which can be severe in many patients. And not only this, patient viral load is not cleared, but only reduced by up by to 80% in some patients.
Therefore CytoDyn does NOT have a curative treatment with their Antibody unlike BioClonetics Clone 3, AND it's NOT proven to be effect on most strains of HIV like Clone 3 is!
My point??? BioClonetics runs circles around Cytodyn but yet within the past 52 weeks their stock price SOARED up to $10, although it is presently trading in the $2 range. This range is where BioClonetics-Enzlytics should be trading right now just based on what they have!
AMEN!!! I can DEFINITELY vouch for that! I'm from the same arena these guys come from!
Just a FEW of Dr. Joseph Cotropia's Patents including Clone3
https://patents.justia.com/search?q=joseph+Cotropia
Search Patents
Human Monoclonal Antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
Patent number: 5459060
Abstract: Disclosed is a human monoclonal antibody produced by the hybridoma designated Clone 3 and having A.T.C.C. Accession No. CRL 10198. The Clone 3 human monoclonal antibody immunologically binds to a conserved epitope on the transmembrane envelope glycoprotein gp41 of Human Immunodeficiency Virus Type 1 (HIV-1) having the amino acid sequence GCSGKLIC.
Type: Grant
Filed: December 26, 1990
Date of Patent: October 17, 1995
Assignee: Bioclonetics Incorporated
Inventor: Joseph P. Cotropia
Human Monoclonal Antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
Patent number: 6083504
Abstract: A method for neutralizing HIV-1 is disclosed. A preferred embodiment utilizes a novel human monoclonal antibody that binds to a conserved region of the gp41 transmembrane subunit of the virus. The antibody is produced by continuous cell lines developed using human B lymphocyte cells collected from a patient possessing high titers of anti-HIV antibodies. The conserved region bound by the neutralizing antibody is a peptide of approximately 12 amino acids in length. Similar regions on HIV-2 and SIV are also disclosed.
Type: Grant
Filed: August 24, 1989
Date of Patent: July 4, 2000
Assignee: Bioclonetics Incorporated
Inventor: Joseph P. Cotropia
Human Monoclonal Antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
Patent number: 6008044
Abstract: A method for neutralizing the retrovirus Human Immunodeficiency Virus-1 (HIV-1) through free virus neutralization or fusion inhibition, comprises adding to a cell mixture of HIV-infected and uninfected cells, a neutralizing agent which specifically binds to at least a portion of the amino acid sequence R-Leu-Ile-Cys-R', where R is either absent or a sequence of 1 to 5 amino acids selected from the group consisting of Lys, Gly-Lys, Ser-Gly-Lys, Cys-Ser-Gly-Lys and Gly-Cys-Ser-Gly-Lys, and R' is either absent or a sequence of 1 to 2 amino acids selected from the group consisting of Thr and Thr-Thr, under conditions effective for allowing said neutralizing agent to inhibit fusion between said HIV-1 infected cells or free HIV-1 and said uninfected cells or administering the neutralizing agent orally, intravenously, or intramuscularly under conditions effective for allowing said neutralizing agent to inhibit fusion between HIV-1 infected cells and uninfected cells.
Type: Grant
Filed: July 1, 1998
Date of Patent: December 28, 1999
Assignee: BioClonetics
Inventor: Joseph P. Cotropia
Human Monoclonal Antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
Patent number: 5777074
Abstract: A method for neutralizing HIV-1 is disclosed. A preferred embodiment utilizes a novel human monoclonal antibody that binds to a conserved region of the gp41 transmembrane subunit of the virus. The antibody is produced by continuous cell lines developed using human B lymphocyte cells collected from a patient possessing high titers of anti-HIV antibodies. The conserved region bound by the neutralizing antibody is a peptide of approximately 12 amino acids in length and preferably 8-10 amino acids. Similar regions on HIV-2 and SIV are also disclosed. The present invention is further directed to a kit and a method for detecting the presence and determining concentration of an antibody that inhibits HIV-1 fusion-associated epitope, a peptide on gp41 with the amino acid sequence represented by GCSGKLIC. The detection and quantitation method includes an enzyme-linked immunosorbent assay (ELISA).
Type: Grant
Filed: February 10, 1995
Date of Patent: July 7, 1998
Assignee: BioClonetics Incorporated
Inventor: Joseph P. Cotropia
This cat's a Heavy Hitter!
As an M.D. Clinical Trials Professional of 30 years, I can tell you that by bringing Dr. Moss on board, this is substantially positive news and it serves to strengthen this Company's objectives toward achieving their intended goals. They couldn't have brought a more qualified medical profession on board with clinical trials/regulatory agency experience, ties to Big Pharma, NIH, and also has expertise in drug development and Immunology. This is MAJOR GOOD NEWS!!...A Home Run Hit for this Company!
But so is the funding beginning to come into place:
The Company has also procured a commitment for funding of $500,000.00 and has received the first tranche of $250,000. These funds are earmarked for implementation of the planned combined operations and the initial steps of the merged business strategy of creating successful therapeutics against infectious diseases thereby increasing the value of the Company's extensive technology.
The second Tranche of funding will be received upon completion of the business combination documents. As part of the initial $500,000.00 funding, the Company and certain of its current convertible debt holders have agree to a 30-day standstill on issuance of any additional shares from conversions of debt.
Enzolytics has begun the process of bringing its filings current having filed the September 30, 2018, December 31, 2018 and March 31, 2019 reports.
ALL GREAT NEWS ACROSS THE BOARD!!!
Great BUYING Opportunity! Just SNAPPED up another several thousand shares!
Accumulate on all drops, and continue HOLDING is the name of that tune!
Eventually it will PAY you in a manner that's beyond your wildest imaginations!
The way I see it, anyone investing in this Biotech needs to thoroughly understand what this is, what this Company has.
Fundamentally, it has the ability to change humanity for the better quite literally. Not just HIV neutralization, but many other terrible infectious disease viruses including Covid-19. These things take time, but not as long as you might think.
As a physician and clinical investigator from the Big Pharma industry for over 30 Years, I can reassure everyone here that there is no other opportunity like this in existence. It is a ONCE in a lifetime opportunity that will radically change your life overnight IF you have the stomach and patience for this Company to bring all the pieces together which I perceive they're doing as fast as they possibly can.
I know what this is and there is nothing that's going to shake me out of my shares, NOTHING! I will just keep accumulating on all drops like today. I don't care if it returns to 0.005 or lower, I will still accumulate in a MAJOR WAY well into the Multi-Millions of Shares!
At some point, this stock is going to soar to the stars! I believe in fact that it can an will make a "several dollar run" in a single day, multiple times over, in the not so distance future.
I encourage every to take a long hard look at Cytodyn and see what happened to that company.....if you check it's 52 Week trading history, the PPS went from $0.52 to $10 with ZERO revenue, ZERO completion of clinical trials, and an inferior Monoclonal Ab that's by far of a lesser magnitude in treatment application compared to BioClonetics-Enzolytics's Clone3 Ab.
Have Faith!
Be well and prosper . . .
AMEN! People like this have nothing better to do and/or are not sure of themselves. What he's doing is complaining about an OTC stock that he clearly thinks should behave like a NASDQ/NYSE Stock. Nothing could be more disingenuous.
Why all your lengthy moaning and complaining?? What does it "profit" you??
Why are you wasting your time posting here?? Isn't it enough to know that ALL OTC stocks are very HIGH RISK and most don't pan out...BUT also keep in mind that "Once Upon A Time" APPLE & AMAZON were BOTH OTC Stocks that made MANY PEOPLE who invested in them Multi-Mega Millionaires!!!
It's very clear based on what you are saying that you shouldn't be in the OTC Market, it's far too risky for you, so therefore, EXIT and head over to NASDAQ or NYSE where you can feel more comfortable about putting your money into stocks, but then again, a large percentage of them don't work out either which is just the nature of the Stock Market for a variety of reasons as you well know.
Based on what you're saying, the OTC is definitely NOT where you should be putting your money, you have far too many objections for which should be obvious to anyone in OTC Stocks. Most of them are indeed SCAMS!! That's a BIG PART OF THE RISK NOW ISN'T IT!, and it's only something that can be sorted out by DD, which still is no guarantee, but it's better than being a FOOL!
Lastly, any intelligent person who plays the Stock Market knows full well that they can lose some or ALL of their money in the Market, again, for a variety of reasons. Fewer lackluster or non-performing Companies on NASDAQ/NYSE??? Yes, of course but you trade at much higher premiums. Guaranteed profits?? Of course not.
The take away...if the risk to reward ratio is to high for you, then stay out of the stock market, in particular the OTC.
Any all ALL Stock Market Investors know this, despite some stock investments being better and safer than others, but yet NONE of them are a guaranteed bet.
Sounds like you should be invested in stocks like Apple, Amazon, Tesla, etc, but do yourself a favor and cease from all the self-torment...simply STAY OUT OF THE OTC...IT'S DEFINITELY NOT FOR YOU...FAR TOO MUCH RISK!
Please be real and cease from playing foolish mind games with yourself!!
Well said!There's no other Biotech Company in history sitting on what BioClonetics-Enzolytics has! There's simply nothing that compares to it!
Post-Merger, they have the potential of rapidly becoming the largest Market Cap Biotech traded on the Stock Exchange, keeping in mind that many of them commonly trade at 40-to-80X earnings!
The way I see it playing out is as follows IMO:
1). Post-Merger combined with coming current on ALL filings, and BioClonetics 135M valuation factored in: PPS easily $0.50-to-1.00
2). Funding from various sources: $1.25-to-1.50
3). Primate Studies under way at UC Davis: $1.55-to-$1.75
4). Confirmation of the Clone3's efficacy on Primates (in-Vivo) as it was in-Vitro: $2.50-to-$3.75
5). Transitioning to Clinical Trials Phase I-IV: $3.85-$5.25
6). Validated preliminary results from Clinical Trials: $5.50 to $15.00
7). FDA Application for commercialization and distribution: $15-$50
8). Big Pharma partner named for manufacturing, marketing, and global distribution. $55-to-$85
9). Transition to NASDAQ with Institutional Interest/Stock Purchasing: $95 -to-$125
10). Earning beginning to fall to bottom line: $150-$225
11). Post Big Pharma Buy Out: $300+
Again, just my opinion. Many other factors will obviously come into play as well I didn't mention, i.e. the commercialization of Enzolytics ITV-1 in the U.S. that will likely occur within 6 months of the Merger.
Just luv these discount prices!
Just snapped up another Mill